A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Clinical trial NCT07029828 · RECRUITING

Trial details

NCT number: NCT07029828
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Alopecia Areata

Start date: 2025-09-10
Primary completion: 2030-06-26
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.